The Mosaic Company (MOS) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call shows strong demand and stable prices in phosphate and potash markets, with positive EBITDA expectations. However, concerns over workforce turnover, institutional knowledge gaps, and potential demand deferral in Q4 phosphate sales create uncertainties. Despite operational improvements and cost reduction plans, the unclear management responses in the Q&A section add to the mixed sentiment. The neutral rating reflects these balancing positive and negative factors.
Key Financial Performance
Net Income Net income for the third quarter increased to $411 million versus $122 million in the prior year, driven by higher prices across all segments and very strong performance in Mosaic Fertilizantes.
Adjusted EBITDA Adjusted EBITDA in the third quarter rose to $806 million from $448 million a year ago, driven by higher prices across all segments and very strong performance in Mosaic Fertilizantes.
Cost Savings Achieved $150 million in initial cost savings and are on track to achieve a revised $250 million cost savings target by the end of 2026, driven by automation, supply chain optimization, and improved fixed cost absorption as production increases.
Phosphate Production Volumes Volumes for the trailing 3-month period ending October reached approximately 1.8 million tonnes, showing improvement from the third quarter due to focus on asset health and consistent performance.
Potash Cash Production Cost Cash production cost per tonne of $71 was down from $75 in Q2 as production volume increased. Expected to remain in the low to mid-70s for the year.
Fertilizantes EBITDA EBITDA came in at $241 million, above the $200 million guided, despite distribution margins being below the targeted range due to a softening market.
Cash Flow from Operations Cash flow from operations was $229 million for the third quarter, impacted by over $400 million increase in working capital due to higher inventories and raw material prices.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Mosaic Biosciences Revenue Growth: Revenues for the first 9 months more than doubled year-over-year. Mosaic Biosciences is expected to contribute positively to consolidated adjusted EBITDA beginning in the fourth quarter.
Brazilian Market Performance: Brazilian fertilizer demand is growing despite tighter credit availability and higher interest rates. Expanded trade opportunities, particularly with China, have supported this growth.
Global Potash Demand: Demand remains strong, especially in China and Southeast Asia, driven by affordability and agricultural needs. Record Canpotex shipments are expected this year.
Cost Savings Initiatives: Achieved $150 million in initial cost savings and on track to reach $250 million by 2026 through automation, supply chain optimization, and improved fixed cost absorption.
Phosphate Production Improvement: U.S. phosphate production has improved for three consecutive quarters, reaching approximately 1.8 million tonnes for the trailing 3-month period ending October.
Potash Production Efficiency: Completed Esterhazy turnaround and implemented HydroFloat system, delivering incremental tonnes. Cash production cost per tonne decreased to $71 in Q3.
Asset Divestments: Sold Taquari potash mine for $27 million and Patos de Minas idle phosphate mine for $111 million, reallocating capital to higher return opportunities.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Fertilizer Affordability Issues: Near-term fertilizer affordability issues are impacting sales volumes and timing, particularly in the U.S. and Brazil. This could affect revenue and operational efficiency.
Challenging Credit Environment in Brazil: The tight credit availability and higher interest rates in Brazil are creating challenges for farmers, impacting fertilizer demand and sales.
Phosphate Production Shortfall: Lower phosphate production volumes and associated higher costs are affecting revenue and operational performance.
Seasonal Demand Variability: Seasonally slower fourth-quarter demand and potential deferral of potash and phosphate purchases into Q1 could impact short-term financial performance.
Inventory and Working Capital Challenges: Higher physical inventories and raw material costs have increased working capital requirements, reducing cash flow from operations in 2025.
Compressed Distribution Margins in Brazil: Distribution margins in Brazil are below target levels due to market softening, impacting profitability.
Regulatory and Market Uncertainties in China: Chinese export restrictions on phosphate fertilizers and growing domestic demand could tighten global supply further, impacting market dynamics.
Cost Pressures in Potash Production: Higher operating costs at certain mines and currency exchange rate fluctuations are affecting potash production costs.
Deferred Capital Allocation: Extraordinary dividends and buybacks are deferred to 2026 due to current cash flow constraints, potentially impacting shareholder returns.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Phosphate Sales Projections: Phosphate sales for Q4 are expected to be between 1.7 million to 1.9 million tonnes, with a downside risk due to demand deferral.
Phosphate Cost Projections: Cash conversion costs for phosphates are expected to decline in Q4 due to normalized asset health, reduced repair work, and higher production.
Potash Cost Projections: Potash cash production costs per tonne are expected to remain similar to Q3 levels, finishing the year in the low to mid-$70s range.
2026 Potash Cost Guidance: 2025 unit production costs for potash are expected to align with the $64 to $69 range, adjusted for current exchange rates.
Fertilizantes Q4 EBITDA Outlook: Q4 EBITDA for Fertilizantes is expected to drop due to lower prices, compressed distribution margins, higher raw material costs, and seasonally lower sales volumes. However, it is still expected to be above the same quarter of the prior year.
2026 Cash Flow Projections: Cash flow from operations and free cash flow are expected to improve significantly in 2026 due to stabilizing raw material prices, consumption of phosphate rock inventories, and inventory adjustments in Brazil and North America.
Capital Reallocation Plans: 2026 is expected to be a year of significant capital reallocation, with ongoing reviews of non-core assets and strategic talks.
Mosaic Biosciences Contribution: Mosaic Biosciences is anticipated to contribute positively to consolidated adjusted EBITDA starting in Q4 2025.
Market Demand Trends: Global potash demand is expected to approach record levels in 2026, driven by strong Chinese consumption, healthy Brazilian imports, and growing Southeast Asian demand. Phosphate markets are also expected to remain constructive due to tight global supplies and growing industrial use.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Extraordinary Dividends: Deferred to 2026 due to current cash flow constraints and working capital increases.
Share Buybacks: Deferred to 2026 due to current cash flow constraints and working capital increases.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can we get an update on the performance in October versus expectations, thoughts on initial November, and confidence in meeting the 4Q production guide?
A:The company is committed to achieving normalized production rates. Issues from September are resolved, but progress is slower than anticipated due to workforce turnover and loss of institutional knowledge. Investments of $100 million in CapEx and $100 million in maintenance have been made to improve operations. The trailing 3-month production ending in October was 1.8 million tonnes, within the guidance range of 1.7-1.9 million tonnes. The company is optimistic about achieving its guidance range.
Q:What is the difference between a good day and a bad day in terms of production targets?
A:A good day involves running without operational upsets, while a bad day involves issues like slower product quality adjustments or shutdowns during product switches. The difference is attributed to operational practices and institutional knowledge rather than structural asset health.
Q:Is the expected phosphate run rate now 1.8 million tonnes, or is there longer-term upside? How should we think about phosphate margins in Q4 versus Q3?
A:The 1.8 million tonnes rate is based on proven performance, but the company is committed to achieving full rates. Fixed cost absorption will improve as production increases. Conversion cash costs were $131 per tonne, with potential reductions to $100-$105 per tonne at 2 million tonnes production. Phosphate margins are highly leveraged to volumes, with significant EBITDA improvements expected as production increases.
Q:What are your thoughts on operating cash flow to EBITDA conversion and potential improvements in free cash flow next year?
A:Operating cash flow to EBITDA conversion is around 50% this year due to inventory and working capital changes. Adjusted for these, the rate is about 70%. By 2026, the conversion rate could exceed 70%, with free cash flow conversion potentially reaching 25-30%. Capital expenditures are expected to decline, and asset retirement obligations are showing a downward trend.
Q:Is it realistic to hit 2 million tonnes per quarter for phosphate given ore grades and asset wear?
A:Ore chemistry is not a concern for hitting 2 million tonnes per quarter. Challenges like overburden removal and pumping distances affect costs but are stable. Rock inventories are being built up to mitigate risks, and consistent operational discipline is emphasized.
Q:Does the fourth quarter phosphate sales volume guide reflect potential demand deferral?
A:The guidance is based on production, with potential demand deferral being a risk. Factors like government payments and weather conditions could influence whether purchases occur in Q4 or are deferred to Q1. Nutrient removal from a large harvest will require replenishment, supporting demand.
Q:What drives fertilizer prices higher in the near term?
A:Fertilizer prices are driven by supply and demand dynamics. Phosphate supply is constrained, with reduced exports from China. Potash supply is tight due to lower output from regions like FSU and Chile. Demand growth, particularly in China and Southeast Asia, supports prices.
Q:What is the impact of the Russian sulfur export ban and ammonia outages on phosphate stripping margins?
A:Stripping margins are expected to decline due to higher sulfur and ammonia costs. However, realized margins remain above historical norms, with potential reductions to the low $4s or upper $3s per tonne. Sulfur prices are influenced by phosphate demand and supply dynamics.
Q:What are the implications of adding phosphate to the critical minerals list?
A:Adding phosphate to the critical minerals list could streamline regulatory frameworks, reduce permitting times, and ensure a stable supply within North America. This would support competitiveness for farmers and maximize food production.
Q:How is finished goods inventory distributed across the supply chain?
A:Finished goods inventory is spread across warehouses in the Midwest, barges on rivers, and finished goods yards in Florida, ensuring readiness for sales as demand returns.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific impact of potential demand deferral on Q4 phosphate sales volume guidance, as it depends on uncertain factors like government payments and weather conditions. Additionally, while they acknowledged challenges in achieving operational consistency, they did not provide detailed timelines or specific measures to address institutional knowledge gaps.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Ag economics
America recovery
Americas market
Brazil buying
Brazil risk
Brazil tonne
Brazil trend
Canpotex shipment
China Southeast
China export
China fertilizer
China soybean
Commercial agriculture
India
LFP battery
Mosaic
Potash market
President Commercial
access advantage
application
asset health
battery demand
capacity addition
capture value
cost saving
demand capture
demand fertilizer
demand record
environment
fall
focus
food
grower soil
market access
market supply
market term
norm
nutrient
potash demand
production asset
resilience
strength
MOS Transcript
The Mosaic Company (MOS) Q1 2026 Earnings Call Transcript
Unknown5-11
The earnings call summary reveals a decline in key financial metrics, including revenue, gross margin, net income, and EPS, all down significantly year-over-year. The absence of discussions on operational updates, strategic initiatives, or shareholder returns suggests a lack of positive catalysts. The Q&A section provided no additional clarity or positive sentiment. The forward-looking statements highlight significant risks, and no guidance or optimistic outlook was offered to counterbalance the negative financial results. These factors collectively suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
The Mosaic Company (MOS) Q4 2025 Earnings Call Transcript
Unknown2-25
The earnings call summary presents a mixed outlook. While there are positive aspects like potential working capital release from excess inventory and optimistic production targets, there are also challenges such as farmer affordability issues and high sulfur prices impacting margins. The Q&A indicates management's optimism but also highlights uncertainties, particularly in pricing and cost management. Overall, the sentiment is balanced with both positive and negative factors, leading to a neutral stock price prediction.
The Mosaic Company (MOS) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call shows strong demand and stable prices in phosphate and potash markets, with positive EBITDA expectations. However, concerns over workforce turnover, institutional knowledge gaps, and potential demand deferral in Q4 phosphate sales create uncertainties. Despite operational improvements and cost reduction plans, the unclear management responses in the Q&A section add to the mixed sentiment. The neutral rating reflects these balancing positive and negative factors.
The Mosaic Company (MOS) Q2 2025 Earnings Call Transcript
Unknown8-6
Despite some positive aspects like improved production in August and strong performance in Biosciences, there are concerns over extraordinary phosphate costs and unclear responses regarding cost ramp-down. Positive factors like increased potash production and potential Q3 EBITDA growth are balanced by these uncertainties, leading to a neutral sentiment. The lack of specific guidance on certain issues and the market's negative reaction to extraordinary expenses add to the mixed outlook.
MOS Slides
MOS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
